Registered number
09004411
Artemida Pharma Ltd
Filleted Accounts
30 April 2023
Artemida Pharma Ltd
Registered number: 09004411
Balance Sheet
as at 30 April 2023
Notes 2023 2022
£ £
Fixed assets
Tangible assets 3 8,322 7,735
Investments 4 151 151
8,473 7,886
Current assets
Debtors 5 119,082 150,916
Cash at bank and in hand 63,912 181,843
182,994 332,759
Creditors: amounts falling due within one year 6 (52,134) (217,350)
Net current assets 130,860 115,409
Net assets 139,333 123,295
Capital and reserves
Called up share capital 76 76
Profit and loss account 139,257 123,219
Shareholders' funds 139,333 123,295
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Robert Miller
Director
Approved by the board on 24 October 2023
Artemida Pharma Ltd
Notes to the Accounts
for the year ended 30 April 2023
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Fixtures, fittings, tools and equipment 25% on reducing balance
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Current and deferred tax assets and liabilities are not discounted.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2023 2022
Number Number
Average number of persons employed by the company 2 5
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 May 2022 24,876
Additions 3,361
At 30 April 2023 28,237
Depreciation
At 1 May 2022 17,141
Charge for the year 2,774
At 30 April 2023 19,915
Net book value
At 30 April 2023 8,322
At 30 April 2022 7,735
4 Investments
Investments in
subsidiary
undertakings
£
Cost
At 1 May 2022 151
At 30 April 2023 151
Subsidiary Undertakings
The following were subsidiary undertakings of the Company:
Name Country of incorporation Class of share Holding Principle activities
Artemida Pharma Europe Ltd Ireland 100 Ordinary shares 100% Pharma Research Consultancy
of Euro 1 each
The aggregate of the share capital and reserves as at 30 April 2023 and of the profit or loss for the year ended on that date for the subsidiary undertakings were as follows:
Aggregate of shares capital and reserves
Euro
Artemida Pharma Europe Ltd (1,764)
5 Debtors 2023 2022
£ £
Trade debtors 44,995 61,079
Other debtors 74,087 89,837
119,082 150,916
6 Creditors: amounts falling due within one year 2023 2022
£ £
Bank loans and overdrafts 706 2,260
Trade creditors 27,090 34,368
Amounts owed to group undertakings and undertakings in which the company has a participating interest (23,051) 44,107
Taxation and social security costs 17,582 108,619
Other creditors 29,807 27,996
52,134 217,350
7 Controlling party
The ultimate controlling parties are the Directors jointly.
8 Other information
Artemida Pharma Ltd is a private company limited by shares and incorporated in England. Its registered office is:
Stevenage Bioscience Catalyst
Gunnels Wood Road
Stevenage
Hertfordshire
SG1 2FX
Artemida Pharma Ltd 09004411 false 2022-05-01 2023-04-30 2023-04-30 VT Final Accounts April 2022 Robert Miller No description of principal activity 09004411 2021-05-01 2022-04-30 09004411 core:WithinOneYear 2022-04-30 09004411 core:ShareCapital 2022-04-30 09004411 core:RetainedEarningsAccumulatedLosses 2022-04-30 09004411 2022-05-01 2023-04-30 09004411 bus:PrivateLimitedCompanyLtd 2022-05-01 2023-04-30 09004411 bus:AuditExemptWithAccountantsReport 2022-05-01 2023-04-30 09004411 bus:Director40 2022-05-01 2023-04-30 09004411 core:PlantMachinery 2022-05-01 2023-04-30 09004411 countries:England 2022-05-01 2023-04-30 09004411 bus:FRS102 2022-05-01 2023-04-30 09004411 bus:FullAccounts 2022-05-01 2023-04-30 09004411 2023-04-30 09004411 core:WithinOneYear 2023-04-30 09004411 core:ShareCapital 2023-04-30 09004411 core:RetainedEarningsAccumulatedLosses 2023-04-30 09004411 core:PlantMachinery 2023-04-30 09004411 2022-04-30 09004411 core:PlantMachinery 2022-04-30 iso4217:GBP xbrli:pure